{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:48Z","timestamp":1791247968166,"version":"4.1.0"},"reference-count":39,"publisher":"Radiation Research Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:p>Diffuse intrinsic pontine gliomas (DIPG) are highly aggressive and treatment-resistant childhood primary brainstem tumors with a median survival of less than one year after diagnosis. The prevailing standard of care for DIPG, radiation therapy, does not prevent fatal disease progression, with most patients succumbing to this disease 3\u20138 months after completion of radiation therapy. This underscores the urgent need for novel combined-modality approaches for enhancing therapy responses. This study demonstrates that the cellular redox modulating drug, copper (II)-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) dose-dependently (1\u20133 \u00b5M) decreased clonogenic cell survival in SU-DIPG50 and SU-DIPG36 cell lines during 6 h of exposure but had no significant effect on survival in normal human astrocytes (NHA). Additional significant (&gt;90%) decreases in DIPG clonogenic survival were observed at 24 h of Cu-ATSM exposure. However, NHAs also began to show dose-dependent 10\u201370% survival decreases at this point. Notably, 3 \u00b5M CuATSM for 6 h resulted in additive clonogenic cell killing of DIPG lines when combined with radiation, which was not seen in NHAs and was partially inhibited by the copper chelator, bathocuproinedisulfonic acid. Cu-ATSM toxicity in DIPG cells was also inhibited by overexpression of mitochondrial-targeted catalase. These results support the hypothesis that Cu-ATSM is selectively cytotoxic to DIPGs by a mechanism involving H2O2 generation and copper and being additively cytotoxic with ionizing radiation.<\/jats:p>","DOI":"10.1667\/rade-24-00076.1","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T02:36:03Z","timestamp":1730687763000},"page":"10-17","source":"Crossref","is-referenced-by-count":2,"title":["Additive Effects of Cu-ATSM and Radiation on Survival of Diffuse Intrinsic Pontine Glioma Cells"],"prefix":"10.1667","volume":"203","author":[{"given":"Sarah A.","family":"King","sequence":"first","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane R.","family":"Solst","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H.","family":"Graham","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna Z.","family":"Fiore","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rheem","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Tomanek-Chalkley","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Fath","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Caster","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Spitz","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Howard","sequence":"additional","affiliation":[{"name":"Free Radical and Radiation Biology Program, B180 Medical Laboratories, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"20","doi-asserted-by":"publisher","unstructured":"H. Aebi,  \"Methods Enzymol.\"  105, \"Catalase in vitro.\" 121 (1984)","DOI":"10.1016\/s0076-6879(84)05016-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"RF Beers  and IW Sizer  \"J Biol Chem.\"  195, \"A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.\" 133 (1952)","DOI":"10.1016\/S0021-9258(19)50881-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"EI Azzam, JP Jay-Gerin, D Pain,  \"Cancer Lett.\"  327, \"Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury.\" 48 (2012)","DOI":"10.1016\/j.canlet.2011.12.012"},{"key":"1","doi-asserted-by":"crossref","unstructured":"K. Warren,  \"Front Oncol.\"  2, \"Diffuse intrinsic pontine glioma: poised for progress.\" (2012)","DOI":"10.3389\/fonc.2012.00205"},{"key":"2","doi-asserted-by":"crossref","unstructured":"W Long, Y Yi, S Chen, et al.  \"Front Pharmacol.\"  8, \"Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.\" 495 (2017)","DOI":"10.3389\/fphar.2017.00495"},{"key":"3","doi-asserted-by":"crossref","unstructured":"QT Ostrom, H Gittleman, J Fulop, et al.  \"Neuro Oncol.\"  17, \"CBTRUS statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012.\" iv1 (2015)","DOI":"10.1093\/neuonc\/nov189"},{"key":"4","doi-asserted-by":"crossref","unstructured":"QT Ostrom, N Patil, G Cioffi, et al.  \"Neuro Oncol.\"  22, \"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017.\" iv1 (2020)","DOI":"10.1093\/neuonc\/noaa200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"JS Rechberger, VM Lu, L Zhang, et al.  \"Childs Nerv Syst.\"  36, \"Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.\" 39 (2020)","DOI":"10.1007\/s00381-019-04363-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"N Aykin-Burns, I Ahmad, Y Zhu, et al.  \"Biochem J.\"  418, \"Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation.\" 29 (2009)","DOI":"10.1042\/BJ20081258"},{"key":"7","doi-asserted-by":"crossref","unstructured":"J Schoenfeld, Z Sibenaller, K Mapuskar, et al.  \"Cancer Cell.\"  31, \"O2\u2013 and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate.\" 487 (2017)","DOI":"10.1016\/j.ccell.2017.02.018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"V Purohit, D Simeone, C Lyssiotis,  \"Cancers.\"  11, \"Metabolic regulation of redox balance in cancer.\" 955 (2019)","DOI":"10.3390\/cancers11070955"},{"key":"9","doi-asserted-by":"crossref","unstructured":"M Petronek, J Stolwijk, S Murray, et al.  \"Redox Biol.\"  42, \"Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.\" 101864 (2021)","DOI":"10.1016\/j.redox.2021.101864"},{"key":"11","doi-asserted-by":"crossref","unstructured":"P Lelievre, L Sancey, JL Coll, et al.  \"Cancers (Basel).\"  12, \"The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy.\" 3594 (2020)","DOI":"10.3390\/cancers12123594"},{"key":"12","doi-asserted-by":"crossref","unstructured":"X Shi, Y Ohta, Y Nakano, et al.  \"Neurosci Res.\"  166, \"Neuroprotective effect of CuATSM in mice stroke model by ameliorating oxidative stress.\" 55 (2021)","DOI":"10.1016\/j.neures.2020.05.009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"XY Choo, LE McInnes, A Grubman, et al.  \"Int J Mol Sci.\"  23, \"Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex.\" 10722 (2022)","DOI":"10.3390\/ijms231810722"},{"key":"14","doi-asserted-by":"crossref","unstructured":"A Samuni, M Chevion, G Czapski,  \"Radiat Res.\"  99, \"Roles of copper and O(2) in the radiation-induced inactivation of T7 bacteriophage.\" 562 (1984)","DOI":"10.2307\/3576330"},{"key":"15","doi-asserted-by":"crossref","unstructured":"GR Walke, S Meron, Y Shenberger, et al.  \"ChemistryOpen.\"  10, \"Cellular Uptake of the ATSM-Cu(II) Complex under Hypoxic Conditions.\" 486 (2021)","DOI":"10.1002\/open.202100044"},{"key":"16","doi-asserted-by":"crossref","unstructured":"MA Cater, HB Pearson, K Wolyniec, et al.  \"ACS Chem Biol.\"  8, \"Increasing intracellular bioavailable copper selectively targets prostate cancer cells.\" 1621 (2013)","DOI":"10.1021\/cb400198p"},{"key":"17","doi-asserted-by":"crossref","unstructured":"SR Solst, KA Mapuskar, CH Graham, et al.  \"Radiat Res.\"  200, \"Rapid Peroxide Removal Limits the Radiosensitization of Diffuse Intrinsic Pontine Glioma (DIPG) Cells by Pharmacologic Ascorbate.\" 456 (2023)","DOI":"10.1667\/RADE-23-00006.1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"KE Brandt, KC Falls, JD Schoenfeld, et al.  \"Redox Biol.\"  14, \"Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.\" 82 (2018)","DOI":"10.1016\/j.redox.2017.08.017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"DR Spitz, JH Elwell, Y Sun, et al.  \"Arch Biochem Biophys.\"  279, \"Oxygen toxicity in control and H2O2-resistant Chinese hamster fibroblast cell lines.\" 249 (1990)","DOI":"10.1016\/0003-9861(90)90489-L"},{"key":"22","doi-asserted-by":"crossref","unstructured":"O Lowry, N Rosebrough, A Farr, et al.  \"J Biol Chem.\"  193, \"Protein measurement with the Folin phenol reagent.\" 265 (1951)","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"K Wada, Y Fujibayashi, N Tajima, et al.  \"Biol Pharm Bull.\"  17, \"Cu-ATSM, an Intracellular-Accessible Superoxide Dismutase (SOD)-Like Copper Complex: Evaluation in an Ischemia-Reperfusion Injury Model.\" 701 (1994)","DOI":"10.1248\/bpb.17.701"},{"key":"24","unstructured":"Y Fujibayashi, H Taniuchi, Y Yonekura, et al.  \"J Nucl Med.\"  38, \"Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.\" 1155 (1997)"},{"key":"25","doi-asserted-by":"crossref","unstructured":"H Matsumoto, Y Yoshii, A Baden, et al.  \"Transl Oncol.\"  12, \"Preclinical pharmacokinetic and safety studies of copper-diacetyl-bis(N4-Methylthiosemicarbazone) (Cu-ATSM): Translational studies for internal radiotherapy.\" 1206 (2019)","DOI":"10.1016\/j.tranon.2019.05.017"},{"key":"26","doi-asserted-by":"crossref","unstructured":"KW Yeom, RM Lober, MD Nelson, et al.  \"J Neurooncol.\"  122, \"Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma.\" 383 (2015)","DOI":"10.1007\/s11060-015-1726-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"D Castel, C Philippe, R Calmon, et al.  \"Acta Neuropathol.\"  130, \"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.\" 815 (2015)","DOI":"10.1007\/s00401-015-1478-0"},{"key":"28","unstructured":"L Hoffman, S Veldhuijzen van Zanten, N Colditz, et al.  \"J Clin Oncol.\"  36, \"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries.\" 1963 (2018)"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Q Fuchs, M Pierrevelcin, M Messe, et al.  \"Cancers (Basel).\"  12, \"Hypoxia inducible factors' signaling in pediatric high-grade gliomas: role, modelization and innovative targeted approaches.\" 979 (2020)","DOI":"10.3390\/cancers12040979"},{"key":"30","doi-asserted-by":"crossref","unstructured":"R Ceschin, M Kocak, S Vajapeyam, et al.  \"J Neurooncol.\"  143, \"Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.\" 79 (2019)","DOI":"10.1007\/s11060-019-03133-y"},{"key":"31","doi-asserted-by":"crossref","unstructured":"JL Dearling  and AB Packard  \"Nucl Med Biol.\"  37, \"Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM.\" 237 (2010)","DOI":"10.1016\/j.nucmedbio.2009.11.004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"CPW Soon, PS Donnelly, BJ Turner, et al.  \"J Biol Chem.\"  286, \"Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (CuII(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model.\" 44035 (2011)","DOI":"10.1074\/jbc.M111.274407"},{"key":"33","doi-asserted-by":"crossref","unstructured":"LW Hung, VL Villemagne, L Cheng, et al.  \"J Exp Med.\"  209, \"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.\" 837 (2012)","DOI":"10.1084\/jem.20112285"},{"key":"34","doi-asserted-by":"crossref","unstructured":"X Zhang  and Z Zhang  \"Trends Cancer.\"  5, \"Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma.\" 799 (2019)","DOI":"10.1016\/j.trecan.2019.10.009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"P Buczkowicz, U Bartels, E Bouffet, et al.  \"Acta Neuropathol.\"  3, \"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.\" 573 (2014)","DOI":"10.1007\/s00401-014-1319-6"},{"key":"36","unstructured":"P Buczkowicz, C Hoeman, P Rakopoulos, et al.  \"Nat Genet.\"  46, \"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.\" 451 (2014)"},{"key":"37","doi-asserted-by":"crossref","unstructured":"D-A Khuong-Quang, P Buczkowicz, P Rakopoulos, et al.  \"Acta Neuropathol.\"  124, \"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.\" 439 (2012)","DOI":"10.1007\/s00401-012-0998-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"X Ding, H Xie, YJ Kang,  \"J Nutr Biochem.\"  22, \"The significance of copper chelators in clinical and experimental application.\" 301 (2011)","DOI":"10.1016\/j.jnutbio.2010.06.010"},{"key":"39","doi-asserted-by":"crossref","unstructured":"D Rasoloson, L Shi, C Chong, et al.  \"Biochem J.\"  381, \"Copper pathways in Plasmodium falciparum infected erythrocytes indicate an efflux role for the copper P-ATPase.\" 803 (2004)","DOI":"10.1042\/BJ20040335"}],"container-title":["Radiation Research"],"original-title":[],"link":[{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-24-00076.1\/3450131\/10.1667_rade-24-00076.1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-24-00076.1\/3450131\/10.1667_rade-24-00076.1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:06:34Z","timestamp":1791245194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-203\/issue-1\/RADE-24-00076.1\/Additive-Effects-of-Cu-ATSM-and-Radiation-on-Survival-of\/10.1667\/RADE-24-00076.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rade-24-00076.1","relation":{},"ISSN":["0033-7587","1938-5404"],"issn-type":[{"value":"0033-7587","type":"print"},{"value":"1938-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}